FESCIOF
10.3.2023 00:11:39 CET | Business Wire | Press release
The Future of Education, Science, and Culture International Organizations Forum (FESCIOF) successfully ended its inaugural convening in Riyadh, uniting for the first time the Arab League Educational, Cultural and Scientific Organization (ALECSO), the Islamic World Educational, Scientific and Cultural Organization (ICESCO), and the United Nations Educational, Scientific and Cultural Organization (UNESCO) plus more than 100 international organizations, leveraging the power of collaboration to drive meaningful impact for the future of international organizations in the fields of education, science, and culture.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230309005847/en/
(from left to right) H.E. Mohamed Ould Amar, Director General, ALECSO, H.E. Dr. Salim Al Malik, ICESCO and Costanza Farina, Director, Regional Bureau for Education in the Arab States – UNESCO Representative to Lebanon and Syria (Photo: AETOSWire)
After the forum concluded, the organizers announced their commitment to facilitate further collaboration among international organizations in education, science, and culture. They affirmed the importance of FESCIOF as an innovative effort to align efforts and maximize positive impact through collaboration. Saudi Arabia also took the initiative to host the next two editions of FESCIOF, in 2025 and 2027.
FESCIOF, which featured more than 20 panel sessions with more than 65 speakers under the theme of “Together for Impact in the 21st Century,” aimed to foster insightful discourse and facilitate knowledge exchange to develop a shared vision and identify opportunities for collaboration.
Alongside high-level representatives from UNESCO, ALECSO, and ICESCO, the event facilitated cross-organizational dialogue within a broad ecosystem of change-makers, featuring speakers and attendees from international organizations, including the Islamic Development Bank (IsDB) Group and the United Nations Development Programme (UNDP), as well as experts and thought leaders in organizational design and management from prestigious academic institutions and prominent organizations, such as Harvard Business School, London Business School, INSEAD Blue Ocean Strategy Institute, Google, and Visa, among others.
The representatives from the education, culture and science international organizations reflected on the discussions during the Forum and highlighted its successes, recognizing the value that partnerships between civil society and the private sector bring to the world. During the final session “Preparing the Ground for Future Collaboration,” the panelists, H.E. Mohamed Ouled Amar, Director General of ALECSO; H.E. Dr. Salim Al-Malik, Director General of ICESCO; Costanza Farina, Director Regional Bureau in Beirut and Representative of UNESCO to Lebanon and Syria, emphasized the need to continue working together to create a “Together for Impact” roadmap to achieve shared goals and create a better future for all.
“As organizations and those who are organizing, we need to work at the right time and the right place because the challenge is the value of time,” H.E. Al-Malik said. He also praised the objectives of FESCIOF and said that ICESCO will maximize the conference outcomes and “convert them into action.”
Farina highlighted the interdependence of the three sectors of education, culture, and science, stressing, “we cannot advance on education if we do not advance in science and in culture at the same time.”
Finally, H.E. Mohamed Ould Amar, Director General of ALECSO concluded that “the goals from this Forum are crystal clear, we are working together to achieve them.”
FESCIOF aims to establish a collaborative and trusted global platform for international organizations to come together and capitalize on future opportunities. The event fosters open dialogue and partnership among stakeholders to create a roadmap for international organizations to collaborate more effectively, while establishing a sustainable mechanism for partnerships resulting from the forum.
FESCIOF, which took place from 8-9 March, is jointly organized by the ALECSO and the SNC.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230309005847/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press release
Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno
The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press release
New One-Day Intensive Experience Offered 9 June Ahead of Conference 10-11 June at Tobacco Dock Featuring 10 Stages and 14 Tracks The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom